Epicutaneous Antigen Exposure Primes for Experimental Eosinophilic Esophagitis in Mice

This publication has 53 references indexed in Scilit:

• Anti–interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes
  Journal of Allergy and Clinical Immunology, 2004
• Eosinophilic gastrointestinal disorders (EGID)
  Journal of Allergy and Clinical Immunology, 2004
• Intratracheal IL-13 induces eosinophilic esophagitis by an IL-5, eotaxin-1, and STAT6-dependent mechanism1 1The authors thank Andrea Lippelman for editorial assistance; Drs. Fred Finkelman, Eric Brandt, Simon Hogan, and Paul Foster for helpful discussions and/or reagents; Drs. James and Nancy Lee (Mayo Clinic, Scottsdale, AZ) for the generous supply of anti-MBP; Dr. Debra Donaldson (Wyeth Research, Cambridge, MA) for the generous supply of recombinant IL-13; and Klaus Matthaei (Australian National University, Canberra, Australia) for the original supply of the IL-5 (Balb/c) gene targeted mice.
  Gastroenterology, 2003
• Stat6-Deficient Mice Develop Airway Hyperresponsiveness and Peribronchial Fibrosis during Chronic Fungal Asthma
  The American Journal of Pathology, 2002
• IL-13 induces eosinophil recruitment into the lung by an IL-5– and eotaxin-dependent mechanism
  Journal of Allergy and Clinical Immunology, 2001
• Abrogation of lung inflammation in sensitized Stat6‐deficient mice is dependent on the allergen inhalation procedure
  British Journal of Pharmacology, 2000
• Th2 responses induced by epicutaneous or inhalational protein exposure are differentially dependent on IL-4
  Journal of Clinical Investigation, 2000
• Essential role of Stat6 in IL-4 signalling
  Nature, 1996
• The role of the eosinophil in gastrointestinal diseases
  Current Opinion in Gastroenterology, 1995
• Atopic dermatitis: The skin as a window into the pathogenesis of chronic allergic diseases
  Journal of Allergy and Clinical Immunology, 1995